Enovis (ENOV) Net Cash Flow Growth (5y) (2015 - 2026)
Enovis (ENOV) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Enovis | 1.62 Bn | 1.58 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -14.92% |
| Dec 31, 2025 | -39.21% |
| Oct 3, 2025 | -80.74% |
| Jul 4, 2025 | 15.03% |
| Apr 4, 2025 | -15.34% |
| Dec 31, 2024 | 16.81% |
| Sep 27, 2024 | 37.83% |
| Jun 28, 2024 | -15.80% |
| Mar 29, 2024 | 56.29% |
| Dec 31, 2023 | 18.06% |
| Sep 29, 2023 | -64.64% |
| Jun 30, 2023 | -5.53% |
| Mar 31, 2023 | -41.03% |
| Dec 31, 2022 | -15.79% |
| Sep 30, 2022 | -145.39% |
| Jul 1, 2022 | -62.14% |
| Apr 1, 2022 | -26.58% |
| Dec 31, 2021 | 75.35% |
| Oct 1, 2021 | 103.92% |
| Jul 2, 2021 | -129.25% |